poisar

Stocks · News reference

Natera to Present New Signatera Data at SITC Annual Meeting

Fiscal.ai

Natera announced it will present new data on its Signatera molecular residual disease test at the Society for Immunotherapy of Cancer (SITC) Annual Meeting.

Reference Details

Connected Markets

Poisar stores the source's headline, summary and market tags for reference. Reporting and full article text remain with the original publisher.

Source
fiscal.ai
Observed
Checked
Cadence
Captured once, then retained as an archive reference
Status
fresh

Keep reading